Phase II trial of neoadjuvant docetaxel before radical prostatectomy for locally advanced prostate cancer (Q44926809)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Phase II trial of neoadjuvant docetaxel before radical prostatectomy for locally advanced prostate cancer	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15183967

retrieved

7 December 2017

title

Phase II trial of neoadjuvant docetaxel before radical prostatectomy for locally advanced prostate cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15183967

retrieved

7 December 2017

main subject

phase II clinical trial

0 references

docetaxel

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Robert Dreicer

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15183967

retrieved

7 December 2017

Cristina Magi-Galluzzi

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15183967

retrieved

7 December 2017

Ming Zhou

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15183967

retrieved

7 December 2017

Jason Rothaermel

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15183967

retrieved

7 December 2017

Alwyn Reuther

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15183967

retrieved

7 December 2017

James Ulchaker

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15183967

retrieved

7 December 2017

Craig Zippe

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15183967

retrieved

7 December 2017

Amr Fergany

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15183967

retrieved

7 December 2017

Eric A Klein

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15183967

retrieved

7 December 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15183967

retrieved

7 December 2017

published in

Urology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15183967

retrieved

7 December 2017

volume

63

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15183967

retrieved

7 December 2017

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15183967

retrieved

7 December 2017

page(s)

1138-1142

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15183967

retrieved

7 December 2017

cites work

Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.040

retrieved

7 January 2021

Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.040

retrieved

7 January 2021

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.040

retrieved

7 January 2021

Long-term followup of a randomized trial of 0 versus 3 months of neoadjuvant androgen ablation before radical prostatectomy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.040

retrieved

7 January 2021

Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.040

retrieved

7 January 2021

Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: feasibility and preliminary results

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.040

retrieved

7 January 2021

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.040

retrieved

7 January 2021

Altered β-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.040

retrieved

7 January 2021

Interaction of estramustine with tubulin isotypes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.040

retrieved

7 January 2021

Paclitaxel and docetaxel in prostate cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.040

retrieved

7 January 2021

Morphologic and immunohistochemical changes in prostate cancer after preoperative hormonal therapy. A comparative study of radical prostatectomies

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.040

retrieved

7 January 2021

Initial dissection of the lateral fascia reduces the positive margin rate in radical prostatectomy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.040

retrieved

7 January 2021

International Validation of a Preoperative Nomogram for Prostate Cancer Recurrence After Radical Prostatectomy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.040

retrieved

7 January 2021

Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locally advanced prostate cancer.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.040

retrieved

7 January 2021

Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: a preliminary report

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.040

retrieved

7 January 2021

Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.040

retrieved

7 January 2021

Identifiers

DOI

10.1016/J.UROLOGY.2004.01.040

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15183967

retrieved

7 December 2017

PubMed publication ID

15183967

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15183967

retrieved

7 December 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44926809&oldid=2057924620"